Parkinson's affects more than 1 million people in the US. Only 10 to 20% of people with Parkinson's experience symptoms ...

The progression of Parkinson's disease often requires a change of therapy. An expert explains when this should be done and ...

Tavapadon aims to treat Parkinson’s motor symptoms by mimicking dopamine in a once-a-day oral dose. And the pivotal, ...

we could identify individuals with specific deficiencies and administer oral riboflavin and biotin supplements to those with ...

including thrashing and other sudden movements Change in blood pressure Parkinson's disease has no cure, but there are treatment options to control your symptoms and improve your quality of life ...

People with Parkinson’s disease are to benefit from cutting edge AI technology that allows neuroscientists to safely test medication and treatment on a ‘digital twin’ brain, thanks to a £1m funding ...

Intra-Cellular Therapies is developing Lenrispodun for the treatment of patients with Parkinson's Disease in a phase 2 study.

Anticholinergics and injection of botulinum toxin into the salivary glands are therapeutic options ... in the treatment of erectile dysfunction in PD. Clinical diagnosis of Parkinson's disease ...

Clinical studies have revealed that rasagiline is associated with improved outcomes in patients with early Parkinson's disease (PD ... may be more prone to treatment-emergent adverse ...

a-syn is believed to be a key protein in the disease due to its high prevalence in patients with Parkinson's disease. Treatment with ACI-7104.056 induced an increase in anti-a-syn antibodies on ...

Thus, another clinical candidate in its pipeline would be Risvodetinib [IKT-148009] for the treatment of patients with Parkinson's Disease [PD]. The use of this kinase inhibitor is being explored ...